Nexlizet

Esperion Therapeutics Lipid Lurkers campaign

Esperion campaign sheds light on ‘Lipid Lurkers’ in artery walls

Fresh off earning FDA approval for label expansions for its LDL-C-lowering Nexletol and Nexlizet, Esperion has launched a new marketing campaign.

Andrea Park Jul 16, 2024 8:00am

Esperion cholesterol med Nexletol bottle

Esperion's new Nexletol analyses build its case with doctors

Nov 13, 2020 11:50am

Esperion cholesterol med Nexletol bottle

Esperion launches DTC campaign for Nexletol with all-stock video

Oct 1, 2020 10:40am

doctor working at computer

Esperion ditches drug launch playbook during pandemic

Sep 21, 2020 11:30am